Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Deep Science Ventures and Medicines Discovery Catapult Partner to Accelerate Next‑Generation Brain Treatments

Deep Science Ventures (DSV), a UK-based deeptech venture creator, and Medicines Discovery Catapult (MDC), a life sciences service dedicated to turning drug discovery into commercial breakthroughs, today announced a strategic collaboration to address challenges in delivering medicines into the brain.

PrecisionLife strengthens leadership team with appointments of Dr Pradip Banerjee and Dr Kam Pooni

Appointments bring deep commercial, scaling, life science, healthcare, and diagnostics expertise to accelerate growth and delivery of clinical impact

Oxford, UK – 3 June 2026 – PrecisionLife, a leader in AI-driven precision medicine for chronic diseases, today announced the appointments of Dr Pradip Banerjee, PhD, MBA, as an Independent Non-Executive Director and Dr Kam Pooni, PhD, as Chief Product Officer.

Business Development & Sales Lead

Xampla is seeking a Business Development and Sales Lead (Licensees, Mills and Coaters) to drive commercial growth and take full ownership of how we scale our coatings business globally.

This is about more than sales delivery: it’s about shaping our commercial strategy, building deep partnerships across the paper coatings value chain, and positioning Xampla as a trusted partner for sustainable materials innovation.

ELRIG Drug Discovery 2026

ELRIG’s Drug Discovery 2026 is back at London’s Excel, and as Europe’s leading drug discovery and life sciences conference, it will have scientific tracks covering topics including Next Generation biophysics, microbes to medicines, multiomics, AI in compound discovery and in experimental design, and bioconjugation approaches in oncology.

Subscribe to